Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Gilead woos Cindy Perettie from Roche to lead Kite after Christi Shaw departs
3 years ago
Cell/Gene Tx
Still under clinical hold, Fulcrum locks in seasoned commercial leader as CEO
3 years ago
R&D
President Biden nominates NCI director Monica Bertagnolli to lead NIH
3 years ago
Athenex files for bankruptcy to pave way for firesale of programs, ending 20-year run
3 years ago
Aurinia’s board gets pushback from another shareholder as Iljin follows MKT Capital’s lead
3 years ago
Icahn wins backing from shareholder advisory firm in bid to remove Illumina CEO from board
3 years ago
Gossamer lays off 25% of employees, cuts all programs except PAH drug
3 years ago
Bristol Myers Squibb lays off 48 in New Jersey
3 years ago
Pharma
As Zynlonta sales disappoint, ADC Therapeutics cuts staff and preclinical programs
3 years ago
R&D
Takeda laying off more than 180 workers in Massachusetts
3 years ago
George Scangos joins Voyager board in reunion with Biogen colleague Al Sandrock
3 years ago
Cell/Gene Tx
Novavax lays off hundreds of employees as new CEO goes into rescue mode
3 years ago
Coronavirus
After Rubius collapse and brief stop at Flagship startup, Pablo Cagnoni finds new start at Incyte
3 years ago
R&D
Corrected: Zevra CEO hits the exit as minority shareholder's nominees take board seats
3 years ago
Remember that record biotech IPO party in 2018? There was no ‘happily ever after’
3 years ago
Bioregnum
Exelixis board member resigns after criticism from hedge fund over lack of medical license, race car driving
3 years ago
Aerami Therapeutics CEO Lisa Yañez passes away, chair to lead heart disease biotech
3 years ago
Alessandro Riva takes over Transgene as AstraZeneca walks away from oncolytic virus pact
3 years ago
Deals
Selecta lets go 25% of workforce, pauses PhI/II gene therapy trial
3 years ago
Vivek Ramaswamy is running an anti-“woke,” anti-China presidential campaign. It's a contrast to his time as CEO
3 years ago
Pharma
In a surprise shift, Tony Coles taps his successor as CEO of Bain startup Cerevel
3 years ago
Bioregnum
Sumitomo to make 200+ staff cuts in Massachusetts amid consolidation
3 years ago
Pharma
Exelixis gives more details behind Farallon proxy fight
3 years ago
Thermo Fisher to make another round of layoffs in San Diego
3 years ago
Manufacturing
First page
Previous page
26
27
28
29
30
31
32
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit